These factors not only promote GBM growth but also activate JAK-STAT and NF-κB pathways, which upregulate immune checkpoint molecules and immunosuppressive cytokines within the tumour microenvironment [64,65]. This evidence concerns the gene NFKB1 and glioblastoma.